Biotech Archives - Page 35 of 84 - Boston Life Sciences Times

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

March 10, 2026

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

March 4, 2026

THIS WEEK'S STORIES

Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer

March 10, 2026

ZoomRx Study Finds Routine Pediatric Vaccine Visits May Be Changing After Federal Guidance Shift

March 12, 2026

GoTo Launches AI-Powered Patient Communications Platform for Clinics and Multi-Location Practices

March 10, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

Pretzel Therapeutics Presents Preclinical Data Supporting PX578 Development for POLG Disease

Parabilis Medicines’ Zolucatetide Receives FDA Orphan Drug Designation for Desmoid Tumors

GelMEDIX, Catalent Partner to Develop Stem Cell-Based Therapies for Ocular and Retinal Diseases

MindImmune Secures $5 Million Investment from Alzheimer’s Drug Discovery Foundation to Advance Alzheimer’s Therapy

Innoviva Specialty Therapeutics Receives Strong Rating in 2026 Global Antimicrobial Resistance Benchmark

Most Read

ZoomRx Study Finds Routine Pediatric Vaccine Visits May Be Changing After Federal Guidance Shift

Carna Health Expands Global Chronic Kidney Disease Screening Programs on World Kidney Day

Pretzel Therapeutics Presents Preclinical Data Supporting PX578 Development for POLG Disease

Insulet Reports Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

EDITOR PICKS

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

THIS WEEK'S STORIES

Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer

ZoomRx Study Finds Routine Pediatric Vaccine Visits May Be Changing After Federal Guidance Shift

GoTo Launches AI-Powered Patient Communications Platform for Clinics and Multi-Location Practices

POPULAR CATEGORY

ABOUT US

FOLLOW US